The specimen was sent for further testing at the Mayo Clinic Laboratories (3050 Superior Drive NW, Rochester, MN 55901), and the tumor cells were positive for TFE3 by immunostaining; however, TFE3 fluorescence in situ hybridization testing was negative for rearrangement. The gene discussed is TFE3; the disease is neoplasm.